DYAI Dyadic International, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 12, 2026
$0,46
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$0,3452 haftanın en düşüğü
$1,6052 haftanın en yükseği
Piyasa Değeri (MRQ)
$17M
P/E (TTM)
-2.0
Hisse Başına Kâr (TTM)
$-0.23
Gelir (TTM)
$4M
rozetleriniz
52 Haftlık Aralık
$0–$2
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$6
P/E
-2.0
ROE
522.6%
Net Kâr Marjı
-200.5%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
DYAI Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$0.46
Piyasa Değeri (MRQ)
$17M
P/E (TTM)
-2.0
Hisse Başına Kâr (TTM)
$-0.23
Gelir (TTM)
$4M
ROE (TTM)
522.6%
52 Haftlık Aralık
$0–$2
DYAI Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$3M2017-12-31 → 2025-12-31
Hisse Başına Kâr$-0.232024-12-31 → 2025-12-31
Net kar marjı-200.5%2018-12-31 → 2024-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | DYAI | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | -2.0 | · | · | · | |
| F/S (TTM) | 4.45Y ort. ≈24.0 | ≈24.0 | · | · | |
| F/D (MRQ) | -7.05Y ort. ≈9.8 | ≈9.8 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 27.65Y ort. ≈13.3 | ≈13.3 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | DYAI | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | -195.1%5Y ort. ≈-353.1% | ≈-353.1% | · | · | |
| Net Kâr Marjı (TTM) | -200.5%5Y ort. ≈-319.1% | ≈-319.1% | · | · | |
| ROA (TTM) | -103.9%5Y ort. ≈-58.1% | ≈-58.1% | -74.1% | Aynı seviyede | |
| ROE (TTM) | 522.6%5Y ort. ≈-111.2% | ≈-111.2% | -159.7% | Zayıf |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | DYAI | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 1.75Y ort. ≈5.3 | ≈5.3 | 1.2 | Güçlü likidite | |
| Cari Oran (MRQ) | 1.15Y ort. ≈3.9 | ≈3.9 | 1.2 | Düşük likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | DYAI | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | -11.6%5Y ort. ≈16.0% | ≈16.0% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 1.8%5Y ort. ≈12.3% | ≈12.3% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 14.0% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | DYAI | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue / Employee (Çalışan Başına Gelir) | ≈$618.1K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-27.6%
Sonraki Rapor
Kas 10, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 12, 2026 | $-0.06 | $-0.04 | -60.4% |
| 31 Mart 2026 | May 13, 2026 | $-0.05 | $-0.04 | -22.5% |
| 31 Aralık 2025 | $-0.06 | $-0.05 | -26.4% | |
| 30 Eylül 2025 | $-0.06 | $-0.04 | -35.7% | |
| 30 Haziran 2025 | $-0.06 | $-0.06 | 2.0% | |
| 31 Mart 2025 | $-0.07 | — | — | |
| 31 Aralık 2024 | $-0.05 | $-0.04 | -22.5% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $758.4K | |
| Cost of Revenue | $2M | $1M | $2M | $2M | $2M | $1M | $1M | $1M | $680.2K | |
| R&D Expense | $2M | $2M | $3M | $5M | $8M | $4M | $3M | $2M | $2M | |
| SG&A Expense | $6M | $6M | $6M | $6M | $7M | $6M | $6M | $5M | $5M | |
| Operating Expenses | $10M | $9M | $11M | $13M | $17M | $12M | $11M | $9M | $8M | |
| Operating Income | $-7M | $-6M | $-8M | $-10M | $-15M | $-10M | $-9M | $-8M | $-7M | |
| Interest Income | $284.1K | $457.0K | · | · | · | · | · | · | · | |
| Other Non-op | $-171.8K | $91.7K | $1M | $250.0K | $2M | $731.7K | · | $894.5K | $5M | |
| Income Tax | · | · | · | · | $0 | $31.3K | $10.3K | $-1M | $-66.7K | |
| Net Income | $-7M | $-6M | $-7M | $-10M | $-13M | $-9M | $-8M | $-6M | $-2M | |
| EPS (Basic) | $-0.23 | $-0.20 | $-0.24 | $-0.34 | $-0.47 | · | · | · | · | |
| EPS (Diluted) | $-0.23 | $-0.20 | · | · | · | · | · | · | · | |
| Shares (Basic) | · | · | 28,798,833 | 28,364,482 | · | · | · | · | · | |
| Shares (Diluted) | 32,624,323 | 29,318,123 | · | · | · | · | · | · | · | |
| EBITDA | · | $-6M | $-8M | $-10M | $-15M | · | $-9M | $-8M | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $7M | $7M | $6M | $16M | $21M | $5M | $2M | $6M | |
| Short-term Investments | $3M | $3M | · | · | · | · | · | · | · | |
| Receivables | $1M | $237.0K | $466.2K | $330.0K | $277.8K | $294.2K | $558.5K | $318.7K | $271.0K | |
| Prepaid Expense | $219.1K | $303.1K | $327.8K | $392.2K | $375.8K | $280.6K | $278.0K | $172.0K | $154.6K | |
| Current Assets | $10M | $10M | $8M | $13M | $21M | $30M | $36M | $43M | $50M | |
| Other Non-current Assets | $10.5K | $10.4K | $10.5K | $6.0K | $6.1K | $6.2K | $51.3K | $52.1K | $53.5K | |
| Total Assets | $10M | $10M | $8M | $14M | $21M | $30M | $37M | $43M | $51M | |
| Accounts Payable | $852.0K | $482.3K | $656.4K | $1M | $2M | $1M | $943.4K | $309.1K | $520.3K | |
| Accrued Liabilities | $968.0K | $970.5K | $1M | $955.1K | $709.6K | $489.8K | $566.0K | $399.6K | $148.0K | |
| Current Liabilities | $4M | $2M | $2M | $2M | $3M | $2M | $2M | $849.6K | $768.9K | |
| Capital Leases | · | $34.6K | $88.9K | $0 | · | · | · | · | · | |
| Total Liabilities | $9M | $7M | $2M | $3M | $3M | $2M | · | · | · | |
| Common Stock | $48.4K | $42.1K | $41.1K | $40.8K | $40.5K | $39.7K | $39.6K | $39.0K | $38.9K | |
| Paid-in Capital | $114M | $107M | $105M | $103M | $101M | $98M | $96M | $94M | $94M | |
| Retained Earnings | $-93M | $-86M | $-80M | $-73M | $-64M | $-51M | $-41M | $-33M | $-27M | |
| Treasury Stock | $19M | $19M | $19M | $19M | $19M | $19M | $19M | $19M | $17M | |
| Stockholders' Equity | $1M | $2M | $6M | $11M | $18M | $28M | $36M | $42M | $50M | |
| Liabilities + Equity | $10M | $10M | $8M | $14M | $21M | $30M | $37M | $43M | $51M | |
| Shares Outstanding | 36,187,798 | 29,835,799 | 28,811,061 | 28,563,061 | 28,229,157 | 27,494,157 | 27,359,157 | 26,713,486 | 28,327,811 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $930.2K | $1M | $1M | $2M | $2M | $2M | $1M | $467.2K | $643.4K | |
| Deferred Tax | · | $0 | $0 | · | · | $0 | $0 | · | · | |
| Operating Cash Flow | $-6M | $-4M | $-7M | $-8M | $-11M | $-7M | $-6M | $-4M | $-2M | |
| Investing Cash Flow | $82.1K | $-2M | $7M | $-2M | $5M | $22M | $8M | $3M | $-812.1K | |
| Stock Repurchased | · | · | · | · | · | · | $0 | $2M | $6M | |
| Net Stock Activity | · | · | · | · | · | · | $0 | $-2M | · | |
| Financing Cash Flow | $5M | $6M | $0 | $543.6K | $1M | $255.5K | $550.2K | $-2M | $-6M | |
| Net Change in Cash | $-653.3K | $-8.3K | $720.8K | $-10M | $-5M | $16M | $2M | $-3M | $-8M |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -168.8% | -283.9% | -346.9% | -612.7% | · | -552.2% | -586.1% | · | |
| Net Margin | · | -166.2% | -234.4% | -332.2% | -543.7% | · | -494.2% | -439.4% | · | |
| EBITDA Margin | · | -168.8% | -283.9% | -346.9% | -612.7% | · | -552.2% | -586.1% | · | |
| ROA | · | -64.0% | -62.0% | -55.6% | -50.9% | · | -20.6% | -12.1% | · | |
| ROE | · | -197.5% | -100.4% | -82.2% | -64.9% | · | -22.7% | -13.3% | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 4.0 | 3.6 | 5.5 | 8.2 | · | 22.4 | 50.3 | · | |
| Quick Ratio | · | 3.9 | 3.1 | 2.5 | 6.3 | · | 3.4 | 3.2 | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.4 | 0.3 | 0.2 | 0.1 | · | 0.0 | 0.0 | · | |
| Receivables Turnover | · | 9.9 | 7.3 | 9.6 | 8.4 | · | 3.8 | 4.4 | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $0.08 | $0.20 | $0.39 | $0.65 | · | $1.31 | $1.59 | · | |
| Cash / Share | · | $0.22 | $0.23 | $0.20 | $0.56 | · | $0.18 | $0.09 | · | |
| EPS (TTM) | $-0.23 | $-0.20 | · | · | · | · | · | · | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -11.6% | 20.6% | -1.1% | 21.9% | 50.1% | · | · | · | · | |
| Revenue CAGR 3Y | 1.8% | 13.3% | 21.9% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 14.0% | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | · | |
| Net Income TTM | $-7M | $-6M | $-7M | $-10M | $-13M | $-9M | $-8M | $-6M | · | |
| Market Cap | · | $52M | $46M | $35M | $128M | · | $142M | $50M | · | |
| P/E | -4.1 | -8.8 | · | · | · | · | · | · | · | |
| P/S | · | 14.9 | 16.0 | 12.0 | 53.1 | · | 84.3 | 39.0 | · | |
| P/B | · | 21.1 | 7.9 | 3.2 | 6.9 | · | 4.0 | 1.2 | · | |
| P / Tangible Book | 27.6 | 21.1 | 7.9 | 3.2 | 6.9 | 5.2 | · | · | · | |
| P / Cash Flow | · | -13.1 | -6.9 | -4.3 | -11.3 | · | -24.5 | -11.5 | · | |
| Earnings Yield | -24.5% | -11.4% | · | · | · | · | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $961.1K | $1M | $565.5K | $1M | $966.6K | $393.6K | $817.4K | $2M | $385.9K | $334.6K | $686.5K | $397.1K | $837.2K | $978.1K | $743.7K | $879.6K | |
| Cost of Revenue | $984.2K | $791.8K | $384.6K | $1M | $613.6K | $297.7K | $352.8K | $395.9K | $302.0K | $144.0K | $350.1K | $105.9K | $792.9K | $726.9K | $704.5K | $602.8K | |
| R&D Expense | $332.6K | $476.1K | $458.4K | $571.9K | $629.4K | $495.0K | $545.7K | $460.2K | $515.6K | $522.7K | $852.8K | $716.4K | $917.6K | $810.6K | $584.1K | $743.6K | |
| SG&A Expense | $2M | $2M | $1M | $1M | $1M | $2M | $1M | $1M | $2M | $2M | $2M | $1M | $1M | $1M | $2M | $1M | |
| Operating Expenses | $3M | $3M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | $3M | $3M | $3M | |
| Operating Income | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-202.6K | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | |
| Interest Income | $39.7K | $57.2K | $83.0K | $63.5K | $49.1K | $88.5K | $103.7K | $127.3K | $138.5K | · | · | · | · | · | · | · | |
| Other Non-op | $-69.7K | $-52.0K | $-31.4K | $-50.6K | $-64.7K | $-25.1K | $-20.8K | $-846 | $-2.6K | $116.0K | $96.9K | $105.9K | $137.5K | $1M | $0 | $0 | |
| Income Tax | $0 | $0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-203.5K | $-2M | $-2M | $-2M | $-2M | $-2M | $-956.4K | $-2M | $-2M | |
| EPS (Basic) | $-0.06 | $-0.05 | $-0.04 | $-0.06 | $-0.06 | $-0.07 | $-0.05 | $-0.01 | $-0.07 | $-0.07 | $-0.08 | $-0.06 | $-0.07 | $-0.03 | $-0.07 | $-0.06 | |
| EPS (Diluted) | $-0.06 | $-0.05 | $-0.06 | $-0.06 | $-0.06 | $-0.07 | $-0.05 | $-0.01 | $-0.07 | · | · | · | · | · | · | · | |
| Shares (Basic) | · | · | · | · | · | · | · | · | · | 28,828,282 | · | 28,811,061 | 28,811,061 | 28,761,469 | · | 28,391,894 | |
| Shares (Diluted) | 36,438,703 | 36,397,997 | · | 34,507,530 | 30,102,324 | 29,886,665 | · | 29,503,143 | 29,291,259 | · | · | · | · | · | · | · | |
| EBITDA | $-2M | $-2M | · | $-2M | $-2M | $-2M | · | $-202.6K | $-2M | $-2M | · | $-2M | $-2M | $-2M | · | $-2M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1M | $4M | $5M | $6M | $2M | $5M | $7M | $6M | $6M | $11M | $7M | $7M | $6M | $6M | $6M | $7M | |
| Short-term Investments | $2M | $1M | $3M | $3M | $3M | $2M | $3M | · | · | · | · | · | · | · | · | · | |
| Receivables | $1M | $996.5K | $1M | $916.6K | $715.3K | $221.7K | $237.0K | $352.9K | $249.8K | $246.1K | $466.2K | $417.9K | $767.6K | $754.1K | $330.0K | $235.4K | |
| Prepaid Expense | $418.9K | $174.2K | $219.1K | $339.9K | $85.0K | $210.9K | $303.1K | $374.2K | $126.7K | $242.1K | $327.8K | $484.2K | $136.2K | $284.6K | $392.2K | $448.2K | |
| Current Assets | $6M | $8M | $10M | $12M | $7M | $8M | $10M | $11M | $11M | $13M | $8M | $9M | $11M | $13M | $13M | $15M | |
| Other Non-current Assets | $10.5K | $10.5K | $10.5K | $10.5K | $10.5K | $10.4K | $10.4K | $10.3K | $10.4K | $10.4K | $10.5K | $14.6K | $5.8K | $6.1K | $6.0K | $6.0K | |
| Total Assets | $7M | $8M | $10M | $12M | $8M | $8M | $10M | $11M | $11M | $13M | $8M | $9M | $11M | $13M | $14M | $15M | |
| Accounts Payable | $816.1K | $1M | $852.0K | $1M | $738.8K | $448.4K | $482.3K | $561.8K | $432.5K | $661.2K | $656.4K | $600.1K | $905.9K | $770.4K | $1M | $777.2K | |
| Accrued Liabilities | $1M | $891.4K | $968.0K | $1M | $929.9K | $690.9K | $970.5K | $839.4K | $870.6K | $988.0K | $1M | $620.2K | $909.5K | $863.0K | $955.1K | $987.9K | |
| Current Liabilities | $4M | $3M | $4M | $4M | $4M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $2M | |
| Capital Leases | · | · | · | · | $5.1K | $20.0K | $34.6K | $48.1K | $62.6K | $75.9K | $88.9K | $101.6K | · | · | $0 | · | |
| Total Liabilities | $9M | $8M | $9M | $9M | $9M | $7M | $7M | $7M | $7M | $8M | $2M | $2M | $2M | $2M | $3M | $3M | |
| Common Stock | $48.7K | $48.7K | $48.4K | $48.4K | $42.4K | $42.4K | $42.1K | $41.8K | $41.7K | $41.4K | $41.1K | $41.1K | $41.1K | $41.1K | $40.8K | $40.7K | |
| Paid-in Capital | $114M | $114M | $114M | $113M | $108M | $108M | $107M | $107M | $106M | $106M | $105M | $105M | $104M | $104M | $103M | $103M | |
| Retained Earnings | $-98M | $-95M | $-93M | $-92M | $-90M | $-88M | $-86M | $-85M | $-84M | $-82M | $-80M | $-78M | $-77M | $-74M | $-73M | $-71M | |
| Treasury Stock | $19M | $19M | $19M | $19M | $19M | $19M | $19M | $19M | $19M | $19M | $19M | $19M | $19M | $19M | $19M | $19M | |
| Stockholders' Equity | $-2M | $-407.7K | $1M | $3M | $-529.7K | $923.6K | $2M | $3M | $3M | $5M | $6M | $8M | $9M | $11M | $11M | $13M | |
| Liabilities + Equity | $7M | $8M | $10M | $12M | $8M | $8M | $10M | $11M | $11M | $13M | $8M | $9M | $11M | $13M | $14M | $15M | |
| Shares Outstanding | 36,438,703 | 36,438,703 | 36,187,798 | 36,187,798 | 30,135,798 | · | 29,835,799 | 29,589,371 | 29,477,639 | 29,186,814 | 28,811,061 | 28,811,061 | 28,811,061 | 28,811,061 | 28,563,061 | 28,463,100 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $144.4K | $139.3K | $192.3K | $172.4K | $340.5K | $225.0K | $274.8K | $247.4K | $297.6K | $306.5K | $297.9K | $281.3K | $334.3K | $330.6K | $480.7K | $499.9K | |
| Operating Cash Flow | $-2M | $-2M | $-2M | $-2M | $-130.0K | $-2M | $-696.4K | $-201.1K | $-2M | $-1M | $-923.4K | $-2M | $-2M | $-2M | $-2M | $-2M | |
| Investing Cash Flow | $-356.9K | $1M | $468.2K | $93.4K | $-961.6K | $482.1K | $1M | $-12.0K | $-2M | $-654.9K | $34.2K | $4M | $1M | $3M | $617.9K | $-1M | |
| Financing Cash Flow | · | · | $-1 | $5M | $0 | $24.2K | $24.3K | $0 | $0 | $6M | $0 | $0 | $0 | $0 | $141.5K | $359.7K | |
| Net Change in Cash | $-2M | $-697.8K | $-1M | $3M | $-1M | $-1M | $585.1K | $-211.8K | $-4M | $4M | $-888.1K | $2M | $-532.5K | $579.8K | $-944.8K | $-3M |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -213.7% | -171.3% | · | -165.3% | -178.9% | -508.8% | · | -10.3% | -529.3% | -635.2% | · | -433.2% | -273.6% | -209.6% | · | -211.9% | |
| Net Margin | -221.0% | -176.0% | · | -169.7% | -185.6% | -515.2% | · | -10.4% | -530.0% | -600.6% | · | -406.6% | -257.2% | -97.8% | · | -205.7% | |
| EBITDA Margin | -213.7% | -171.3% | · | -165.3% | -178.9% | -508.8% | · | -10.3% | -529.3% | -635.2% | · | -433.2% | -273.6% | -209.6% | · | -211.9% | |
| ROA | -28.9% | -24.9% | · | -17.6% | -19.1% | -19.7% | · | -2.0% | -18.9% | -15.8% | · | -13.2% | -15.2% | -0.01% | · | -9.3% | |
| ROE | 145.6% | -757.8% | · | -65.6% | -136.0% | -74.6% | · | -3.7% | -33.7% | -26.2% | · | -15.9% | -19.1% | -0.01% | · | -10.5% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 2.4 | · | 2.8 | 2.0 | 4.0 | · | 5.1 | 5.4 | 5.5 | · | 6.2 | 5.5 | 6.8 | · | 6.3 | |
| Quick Ratio | 1.1 | 2.1 | · | 2.4 | 1.6 | 3.9 | · | 3.0 | 3.3 | 4.8 | · | 5.4 | 3.3 | 3.8 | · | 2.9 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.0 | · | 0.2 | 0.0 | 0.0 | · | 0.0 | 0.1 | 0.0 | · | 0.0 | |
| Receivables Turnover | 1.0 | 1.8 | · | 1.8 | 2.0 | 1.7 | · | 5.1 | 0.8 | 0.7 | · | 1.2 | 0.9 | 0.0 | · | 4.2 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.07 | $-0.01 | · | $0.07 | $-0.02 | · | · | $0.12 | $0.11 | $0.15 | · | $0.27 | $0.31 | $0.38 | · | $0.44 | |
| Revenue / Share | $0.03 | $0.03 | · | $0.03 | $0.03 | · | · | · | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $-0.05 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.04 | $0.12 | · | $0.16 | $0.07 | · | · | $0.20 | $0.21 | $0.36 | · | $0.26 | $0.20 | $0.22 | · | $0.24 | |
| EPS (TTM) | $-0.23 | $-0.23 | · | $-0.24 | $-0.19 | $-0.20 | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $4M | · | $3M | $4M | $4M | · | $3M | $2M | $2M | · | $3M | $3M | $3M | · | $-458M | |
| Net Income TTM | $-8M | $-7M | · | $-7M | $-6M | $-6M | · | $-6M | $-8M | $-8M | · | $-7M | $-7M | $-8M | · | $-12M | |
| Market Cap | $33M | $30M | · | $43M | $30M | · | · | $31M | $44M | $49M | · | $55M | $56M | $51M | · | $54M | |
| P/E | -3.9 | -3.6 | · | -4.9 | -5.2 | -6.8 | · | · | · | · | · | · | · | · | · | · | |
| P/S | 8.6 | 7.8 | · | 12.8 | 7.2 | · | · | 9.1 | 24.2 | 21.6 | · | 18.7 | 16.2 | 15.7 | · | -0.1 | |
| P/B | -13.7 | -73.3 | · | 16.4 | -56.3 | · | · | 9.0 | 13.8 | 10.8 | · | 7.2 | 6.2 | 4.7 | · | 4.3 | |
| P / Tangible Book | · | · | · | 16.4 | · | · | · | 9.0 | 13.8 | 10.8 | · | 7.2 | 6.2 | 4.7 | · | 4.3 | |
| P / Cash Flow | · | -15.2 | · | · | · | · | · | · | · | -43.8 | · | · | · | -23.4 | · | · | |
| Earnings Yield | -25.6% | -28.1% | · | -20.3% | -19.2% | -14.8% | · | · | · | · | · | · | · | · | · | · |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $3M | $3M | $3M | $3M | $2M |
| Faaliyet Kâr Marjı % | · | -168.8% | -283.9% | -346.9% | -612.7% |
| Net Gelir | $-7M | $-6M | $-7M | $-10M | $-13M |
| Seyreltilmiş Hisse Başı Kâr | $-0.23 | $-0.20 | · | · | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | · | 4.0 | 3.6 | 5.5 | 8.2 |
| Cari Oran | · | 3.9 | 3.1 | 2.5 | 6.3 |
Bu beyan için veri yok
Bu beyanı oluşturmak için henüz yeterli temel verisi yok.
Kurumsal Sahipler (13F) 44 dosya · $5.4M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
44
Tutulan Değer
$5.4M
Yeni pozisyonlar
6
Çıkan pozisyonlar
3
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 6 (0 önceki Ç'ye göre) | 3 (-3 önceki Ç'ye göre) | 5 (-1 önceki Ç'ye göre) | 8 (+1 önceki Ç'ye göre) | -519K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| VANGUARD GROUP INC | $860.062 | 914.960 | 15,93% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $831.697 | 928.233 | 15,41% | Hisse senetleri |
| CHAPIN DAVIS, INC. | $795.654 | 888.004 | 14,74% | Hisse senetleri |
| Apis Capital Advisors, LLC | $721.174 | 804.882 | 13,36% | Hisse senetleri |
| TRUIST FINANCIAL CORP | $292.275 | 326.200 | 5,42% | Hisse senetleri |
| Northeast Financial Consultants Inc | $247.500 | 250.000 | 4,59% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $224.865 | 250.905 | 4,17% | Hisse senetleri |
| BlackRock, Inc. | $177.183 | 197.749 | 3,28% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $124.972 | 139.478 | 2,32% | Hisse senetleri |
| MARATHON CAPITAL MANAGEMENT | $98.560 | 110.000 | 1,83% | Hisse senetleri |
| Sage Mountain Advisors LLC | $95.481 | 106.564 | 1,77% | Hisse senetleri |
| HighTower Advisors, LLC | $71.204 | 79.469 | 1,32% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $70.592 | 78.786 | 1,31% | Hisse senetleri |
| Callan Capital, LLC | $68.525 | 50.759 | 1,27% | Hisse senetleri |
| CITADEL ADVISORS LLC | $66.605 | 74.336 | 1,23% | Hisse senetleri |
| NORTHERN TRUST CORP | $62.492 | 69.745 | 1,16% | Hisse senetleri |
| CITADEL ADVISORS LLC | $61.645 | 68.800 | 1,14% | Alım opsiyonu |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | $49.515 | 55.263 | 0,92% | Hisse senetleri |
| AE Wealth Management LLC | $48.165 | 53.756 | 0,89% | Hisse senetleri |
| PERKINS CAPITAL MANAGEMENT INC | $43.053 | 48.050 | 0,80% | Hisse senetleri |
| XTX Topco Ltd | $41.812 | 46.665 | 0,77% | Hisse senetleri |
| STATE STREET CORP | $38.125 | 42.550 | 0,71% | Hisse senetleri |
| Pekin Hardy Strauss, Inc. | $37.404 | 41.745 | 0,69% | Hisse senetleri |
| JANE STREET GROUP, LLC | $36.930 | 41.217 | 0,68% | Hisse senetleri |
| AlphaCore Capital LLC | $32.396 | 36.156 | 0,60% | Hisse senetleri |
| ASHTON THOMAS SECURITIES, LLC | $32.395 | 36.155 | 0,60% | Hisse senetleri |
| LPL Financial LLC | $30.946 | 34.538 | 0,57% | Hisse senetleri |
| Inlet Private Wealth, LLC | $26.880 | 30.000 | 0,50% | Hisse senetleri |
| Robertson Stephens Wealth Management, LLC | $26.852 | 29.969 | 0,50% | Hisse senetleri |
| Sabal Trust CO | $15.000 | 11.111 | 0,28% | Hisse senetleri |
| CAPTRUST FINANCIAL ADVISORS | $13.440 | 15.000 | 0,25% | Hisse senetleri |
| COMMONWEALTH EQUITY SERVICES, LLC | $11.270 | 12.579 | 0,21% | Hisse senetleri |
| SIMPLEX TRADING, LLC | $10.630 | 11.864 | 0,20% | Hisse senetleri |
| HANCOCK WHITNEY CORP | $9.955 | 11.111 | 0,18% | Hisse senetleri |
| HOEY INVESTMENTS, INC | $8.823 | 9.847 | 0,16% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $6.617 | 7.385 | 0,12% | Hisse senetleri |
| PNC Financial Services Group, Inc. | $3.584 | 4.000 | 0,07% | Hisse senetleri |
| Tower Research Capital LLC (TRC) | $1.188 | 1.326 | 0,02% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $787 | 878 | 0,01% | Hisse senetleri |
| UBS Group AG | $706 | 788 | 0,01% | Hisse senetleri |
| MORGAN STANLEY | $240 | 268 | 0,00% | Hisse senetleri |
| BARCLAYS PLC | $143 | 159 | 0,00% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $62 | 69 | 0,00% | Hisse senetleri |
| JPMORGAN CHASE & CO | $26 | 29 | 0,00% | Hisse senetleri |
Aktivistler ve %5+ sahipler 3 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| David M. Knott | 05 Ağustos 2009 | · | İlk başvuru | · | SEC |
| 23 Nisan 2008 | · | İlk başvuru | · | SEC | |
| The Pinnacle Fund, L.P., Barry M. Kitt, The Francisco Trust U/A/D February 28, 1996, Mark A. Emalfarb, Tom Juda, Nancy Juda, J. Steven Emerson, David M. Knott ×3 başvurular | 15 Nisan 2008 | · | İlk başvuru | Yönetim kurulu kampanyası | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 21 içeriden öğrenenler · 6 yöneticiler · 10 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Mark A Emalfarb | CEO | 02 Ocak 2026 A | 4.832.667 | 0 | 0 | $0 |
| Ping Wang Rawson | Chief Financial Officer | 02 Ocak 2026 A | 170.151 | 0 | 0 | $0 |
| Joseph P Hazelton | President & COO | 02 Ocak 2026 A | 191.758 | 0 | 0 | $0 |
| Ronen Tchelet | VP of Research and Bus. Dvlpmt | 02 Ocak 2026 A | 50.897 | 0 | 0 | $0 |
| Matthew S. Jones | Managing Dir of BD & Licensing | 04 Ocak 2021 A | · | 0 | 0 | $0 |
| Ratnesh Chandra | Sr VP Mrktng,Biotechnology Sys | 04 Nisan 2006 A | · | 0 | 0 | $0 |
| Seth Herbst | Yönetim kurulu üyesi | 02 Ocak 2026 A | 202.311 | 0 | 0 | $0 |
| Patrick K. Lucy | Yönetim kurulu üyesi | 02 Ocak 2026 A | 72.311 | 0 | 0 | $0 |
| Jack Kaye | Yönetim kurulu üyesi | 02 Ocak 2026 A | 81.201 | 0 | 0 | $0 |
| Arindam Bose | Yönetim kurulu üyesi | 20 Haziran 2025 D | 61.535 | 0 | 0 | $0 |
| Tarnok Michael P. | Yönetim kurulu üyesi | 20 Haziran 2025 M | 281.033 | 0 | 0 | $0 |
| Barry Buckland | Yönetim kurulu üyesi | 11 Haziran 2024 D | 38.967 | 0 | 0 | $0 |
| Stephen J Warner | Yönetim kurulu üyesi | 02 Ocak 2007 A | 0 | 0 | 0 | $0 |
| Richard J Berman | Yönetim kurulu üyesi | 02 Ocak 2007 A | · | 0 | 0 | $0 |
| Robert B Shapiro | Yönetim kurulu üyesi | 02 Ocak 2007 A | · | 0 | 0 | $0 |
| Francisco Trust under agreement dated February 28, 1996 | 10% sahip | 24 Temmuz 2026 S | 3.280.272 | 0 | 10 | $-468.828 |
| Glenn E Nedwin | · | 05 Nisan 2007 A | · | 0 | 0 | $0 |
| Alexander V Bondar | · | 05 Nisan 2007 A | · | 0 | 0 | $0 |
| Kent Michael Sproat | · | 05 Nisan 2007 A | · | 0 | 0 | $0 |
| Wayne Moor | · | 05 Nisan 2007 A | · | 0 | 0 | $0 |
| Harry Z Rosengart | · | 21 Şubat 2007 A | · | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 2 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
DYAI Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 7 analist
AL
Medyan hedef
$5.50
+1106,7%
2 28,6%
Güçlü Al
4 57,1%
Al
1 14,3%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
2 analist · 2026-09-28Ortalama hedef $5.50 +1106,7%
← Tüm hedeflerin altında
Mevcut fiyat $0.46
Düşük$4.00
Ortalama$5.50
Yüksek$7.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| DYAI | · | -4.1 | -11.6% | · | · | · |
| ESLA | · | -4.5 | · | · | · | · |
| JSPR | · | -0.5 | · | · | · | · |
| ACTU | $142M | -5.8 | · | · | -843.5% | · |
| NEUP | $24M | -1.4 | -92.5% | -1145.7% | -49.5% | · |
| SHPH | $4M | -0.3 | 0.00% | · | -400.1% | · |
| CLRB | · | -0.4 | · | · | · | · |
| MRKR | $25M | -1.9 | -46.2% | -343.0% | -89.1% | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 12, 2026